Rigel Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Rigel Pharmaceuticals patents 62 in total
| Status | Patent |
|---|---|
Application | Utility: Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses Filling date: 27 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: Tyrosine Kinase Inhibitors Filling date: 27 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF Filling date: 27 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Prodrugs of NRF2 Activating Compounds and Uses Thereof Filling date: 27 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: AMIDE COMPOUNDS AND METHOD FOR MAKING AND USING Filling date: 27 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Filling date: 27 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER Filling date: 27 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: IRAK INHIBITORS AND METHOD FOR MAKING AND USING Filling date: 27 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses Filling date: 27 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: 2,3-Disubstituted Pyridine Compounds as TGF-Beta Inhibitors and Methods of Use Filling date: 27 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Filling date: 27 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Filling date: 27 Sep 2025 Issue date: 22 Aug 2019 |
Showing 50 to 62 of 62 patents.